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Background: Achieving satisfactory post-operative analgesia with neuraxial administration of narcotics has been the subject of much research. 
The use of epidural opioids had become an increasingly popular technique for management of acute post-operative pain in recent times. This 
study evaluates post-operative analgesic benefits in patients administered epidural butorphanol, nalbuphine, and fentanyl as adjuvants with local 
anesthetics postoperatively for surgery under epidural anesthesia.
Methods: A total of 75 patients belonging to age groups 18-60 years who were scheduled for surgeries of lower abdomen were randomly divided into 
groups of 25 each. Epidural technique was adopted for surgery of the lower abdomen for all patients with 0.5% bupivacaine. In the post-operative 
period, the study drug was given through epidural catheter. Group A received butorphanol 2 mg, Group B received fentanyl 100 μg, and Group C 
received nalbuphine 10 mg with 0.125% bupivacaine diluted to 10 ml in normal saline each. Onset, duration, quality of analgesia, hemodynamic 
changes, and side effects – such as sedation, pruritus, nausea, vomiting, respiratory depression, and urinary retention - were recorded and compared.
Results: The demographic data were comparable in all three groups. The onset of sensory block was significantly earlier in Group B (fentanyl) than 
other two groups. Duration was significantly longer in Group A (butorphanol). No serious cardiorespiratory side effects were noted in any of groups.
Conclusion: Fentanyl produces the faster onset of analgesia with adverse effects like pruritus. Butorphanol administered epidurally has the advantage 
of longer duration of analgesia than fentanyl or epidural nalbuphine with side effects such as nausea, vomiting, and sedation.
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INTRODUCTION
In perioperative scenario pain is now taken up as the sixth vital sign. 
Acute post-operative pain is associated with several adverse events. 
Given the multiplicity of mechanisms involved in post-operative pain, a 
multimodal analgesia regimen using a combination of opioid and non-
opioid analgesics has become the treatment of choice for facilitating 
the recovery process [1,2]. Administration of analgesics through the 
epidural route is a more popular technique for post-operative pain 
management as it can be used alone or in combination with general 
anesthesia [3]. Epidural catheter placed in a location congruent to 
the incisional dermatome has been shown to provide analgesia that 
minimizes the need for systemic analgesics, reduces stress response 
to surgery and pain and facilitates early rehabilitation [4]. Epidural 
analgesia with local anesthetics was found to be very effective in 
pain management [3]. Later on, opioids were used as an adjuvant to 
local anesthetics. The combination was found to be synergistic [3]. 
Advantages of the combination include better pain relief, motor sparing 
and reduced overall toxicity.
Butorphanol is a synthetically derived agonist-antagonist upload 
analgesic. It is an agonist on к receptor and either antagonist or partially 
agonist on μ receptor. Epidural butorphanol has been employed 
successfully for the relief of post-operative pain. It is considered safer 
than pure agonist opioids because of its ceiling effect on respiratory 
depression, lower addiction potential, lesser nausea, vomiting, pruritus, 
and urinary retention. It produces sedation comparable to or more than 
that of morphine, which is desired in post-operative period [4].
Fentanyl, a μ opiate receptor agonist, has analgesic potency greater 
than morphine. It has shorter duration of action and lesser respiratory 
depressant effect as compared to morphine and pethidine [5].
Nalbuphine is an agonist-antagonist opioid analgesic which is 
also synthetically derived. It is equal in potency as an analgesic to 
morphine and is about one-fourth as potent as nalorphine as an 
antagonist. It also has a ceiling effect on respiratory depression. 
Sedation is commonly seen when used in post-operative period as 
an analgesic [3].
This study was conducted to evaluate post-operative analgesic benefits 
in patients administered epidural butorphanol, nalbuphine, and 
fentanyl as adjuvants with local anesthetics postoperatively for surgery 
under epidural anesthesia and to compare their post-operative efficacy 
with respect to increase in duration of analgesia, reduction in total 
requirements of analgesics postoperatively and study side effects and 
complications, if any attributable to these drugs.
METHODS
This study was conducted after its approval by the Ethical Committee of 
Institute of Medical Sciences and Sum Hospital, Bhubaneswar; Odisha, 
India. After explaining in details about the study protocols to all the 
patients and his/her attendants, sometime with multiple interactions, 
written informed consent was obtained from all the patients of all 
the study groups. A total of 75 patients were selected for the study, 
conducted from January 2015 to September 2015.
Type of study
It is a prospective randomized double-blind study.
Patient profile
The study was confined to the hospital inpatients only who were 
scheduled for surgeries of lower abdomen. 75 patients of age ranging 
from 20 to 60 years (25 in each group) of the American Society of 
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Anesthesiologists (ASA) I and ASA II group were selected on the basis 
of inclusion and exclusion criteria outlined below.
Inclusion criteria
a. ASA I and II patients.
b. Surgeries of the lower abdomen.
c. Patients were eligible for enrolment in the study if they 
were >18 years old, within ±50% of their ideal body weight, had 





3. ASA III and IV patients
4. Local infection




9. Spinal level blockade above T6
10. Renal insufficiency
11. Peptic ulcer disease
12. History of drug abuse
13. Patients in whom epidural anesthesia was not adequate and 
supplemented with other types of anesthesia.
Patients were randomly divided into three groups of 25 each.
• Group A - Butorphanol group
• Group B - Fentanyl group
• Group C - Nalbuphine group.
Pre-anesthetic evaluation
Patients were visited on the previous day of the surgery. A detail clinical 
history was taken, Detail general and systemic examinations were done. 
Basic laboratory investigations such as complete hemogram, bleeding 
time, clotting time, blood sugar, blood urea, serum creatinine and urine 
analysis, electrocardiography (ECG), and chest X-ray were carried out 
routinely in all patients.
The patients were explained about the epidural technique with catheter 
in situ and its advantages and disadvantages. They were also educated 
about the usage of linear visual analog scale (VAS) for assessment of 
the intensity of post-operative pain and were instructed to mark on the 
scale at the point which he/she felt was representative of their level of 
discomfort.
A written informed consent was taken from each patient.
Premedication
To allay the anxiety and apprehension, all patients were premedicated 
with Tablet Alprazolam 0.25 mg on the night before the surgery. The 
patients were also kept nil orally for 6 hrs before surgery.
Anesthesia
Epidural technique was adopted for surgery of the lower abdomen for 
all patients with 0.5% bupivacaine. The patient was made to lie supine 
on the operation table. An intravenous line was secured with 18 G canula 
and infusion of 5% Ringer lactate was started. Routine monitors such 
as ECG, noninvasive blood pressure (NIBP), and pulse oximetry were 
connected for every case, and basal vital signs were recorded before 
starting the epidural technique. Drugs and equipment necessary for 
resuscitation and general anesthesia administration were kept ready.
An autoclaved epidural tray was used. The patient was placed in sitting 
or lateral position. Under aseptic precautions, a skin wheal was raised 
at L2-L3 or L3-L4 interspace with 2 ml of 2% lignocaine. The epidural 
space was identified using 18 G disposable Tuohy needle with loss 
of resistance technique. Then, 20 G catheter was passed through the 
epidural needle till about 2-3 cm of the catheter was in the space. The 
needle was withdrawn keeping the inserted epidural catheter in situ and 
was fixed to the back using adhesive tape. 3 ml of 2% lignocaine with 
adrenaline 1:2,00,000 was injected through the catheter as a test dose 
and observed for any untoward reactions including drug interactions as 
well as intravascular or intrathecal injection.
After confirming correct placement of the catheter, epidural anesthesia 
was activated using 16-18 ml bolus dose of 0.5% bupivacaine. 
Subsequent top up doses were given depending on the duration 
of surgery and intensity of pain. No narcotics were administered 
throughout the intraoperative period.
Fluid management
The patients were infused and maintained with crystalloids and 
colloids. Blood was transfused only when indicated.
The following observations were made.
Intraoperative:
• Onset of analgesia.
• Level of sensory blockade (maximum sensory level after 30 minutes).
• BP monitoring (NIBP).
• Heart rate (HR).
• Respiratory rate (RR) and SpO2.
Duration of surgery was also noted.
• Onset of analgesia (sensory block): The time interval between 
administrations of local anesthetic (0.5% bupivacaine) epidurally 
to the loss of pinprick sensation at the site of surgical incision.
• Level of sensory blockade: The maximum sensory dermatome 
level after 30 minutes of administering the local anesthetic (0.5% 
bupivacaine) in the epidural space. The local anesthetics usually get 
fixed to their respective receptors by 20 minutes, and regression of 
two dermatomes usually occurs after 30 minutes.
During intraoperative period, NIBP, HR, RR, and SpO2 were recorded 
before activating epidural anesthesia and subsequently at every 
5 minutes till the end of the surgery.
After the surgery, the patients were shifted to recovery room and 
monitoring was continued. When patients recovered from motor 
blockade, they were shifted to post-operative ward.
Post-operative period
In the post-operative period, when the patients first complained of 
pain, intensity of pain was assessed using VAS scale. When the VAS 
score was >5, study drug was given through epidural catheter after 
confirming its proper position as:
• Group A - Receiv.ed butorphanol 2 mg with 0.125% bupivacaine 
diluted to 10 ml in normal saline.
• Group B - Received fentanyl 100 µg with 0.125% bupivacaine diluted 
to 10 ml in normal saline.
• Group C - Received nalorphine 10 mg with 0.125% bupivacaine 
diluted to 10 ml in normal saline.
The intensity of pain and pain relief was assessed using VAS at 
5,10,15,30,60 minutes and thereafter hourly for 8 hrs and then at 4 hrs 
interval for 24 hrs postoperatively. As and when the patient complained 
of pain during the period of observation, intensity of pain was assessed 
again using VAS to know the effect of the study drug given earlier. If it 
was >5, an intramuscular non-opioid analgesic as per the institutionally 
approved protocol was given.
VAS consisted of a 10 cm line, marked at 1 cm each on which the 
patient makes a mark on the line that represents the intensity of pain 
he/she was experiencing. Mark “0” represents no pain and mark “10” 
represents worst possible pain. The numbers marked by the patient 
was taken as units of pain intensity.
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Linear VAS score
VAS score Intensity of pain




10 Worst possible pain (intolerable)
Following observations were recorded:
1. Onset of analgesia
2. Duration of analgesia
3. Quality of analgesia
4. Cardio- respiratory effects: HR, BP and RR were
5. Side effects such as sedation, pruritis, nausea, vomiting, respiratory 
depression and urinary retention, and hypotension.
Onset of analgesia
The time interval from administration of the study drug (VAS score of >5) 
till VAS score came down to <5.
Duration of analgesia
The time interval between onset of analgesia (VAS score <5), till patient 
complained of pain (VAS score >5) when rescue medication was given.
Quality of analgesia was assessed during the duration of analgesia using 
pain score and compared between all the three groups.
Quality of analgesia
Pain score Pain relief
0 No pain relief
1 Poor pain relief
2 Fair pain relief
3 Good pain relief
4 Excellent pain relief
Side effects
Sedation - quality of sedation after giving the study drug was based on 
sedation scoring.
• Grade 0 - No sedation, patient wide awake.
• Grade 1 - Mild sedation, patient awake but drowsy.
• Grade 2 - Moderate sedation, sleepy but arousable.
• Grade 3 - Severe sedation, unarousable.
Hypotension - Defined as a fall of systolic BP by 20% from basal systolic BP.
Respiratory depression - Bradypnea appears to be a more reliable clinical 
sign of early respiratory depression and a RR<10 breaths/minutes was 
recorded as respiratory depression.
Bradycardia - A fall of HR by 20% from the basal HR.
Other side effects that were observed and compared were pruritus, 
nausea, and vomiting.
Statistical analysis
All data recorded was analyzed using statistical package for social 
sciences (SPSS version 17). Data are expressed as mean with a standard 
deviation. Discreet data are expressed as frequency with percentage 
of total. ANOVA with post hoc test was used to compare continuous 
variables. A p<0.05 was considered significant.
RESULTS
All the three groups were comparable in terms of age, sex and weight, 
duration and type of surgery (Tables 1 and 2).
Onset of analgesia
The mean time of onset of analgesia was 11.24 minutes, 6.32 minutes, 
and 14.64 minutes in Groups A–C, respectively. Statistical analysis 
showed that onset of analgesia was faster in fentanyl group compared 
to other two groups (p<0.05).
Duration of analgesia
The mean duration of analgesia was 481.68 minutes in Group A, 
178.60 minutes in Group B and 294.68 minutes in Group C. The duration 
was thus significantly longer in butorphanol group.
Hemodynamic changes
Fig. 1 shows in all the three groups there was no change observed in 
pulse rate and mean arterial pressure.
The mean RR increased 6-8 hrs onward postoperatively in Group Ι, 
4 hrs onward in Group B and immediately postoperatively in Group C. 
This hyperventilation was probably due to the onset of pain after 
analgesic effect of respective drugs curtailed off over time. The rate 
came down after administration of rescue analgesic, further confirming 
the assumption.
Comparison of mean pain score
Fig. 2 shows the mean pain score recorded was significantly lower in 
Groups A and B than in Group C. All the patients in Groups B and C 
required analgesic supplementation within first 2-4 hrs and 4-6 hrs, 
respectively. Whereas, 9 patients of Group A required supplementation 
within 6-8 hrs, 16 patients between 8 and 10 hrs.
Complications
Table 3 shows, in this study, 12% patients in Group A, 16% patients in 
Group B and 48% patients in Group C had nausea and vomiting. The 
high female proportion in the study group and the fact that pain and 
opioids themselves are emetogenic may be the underlying reasons.
Sedation
This was the main side effect in butorphanol group which constituted 
32% and 20% of the patients in fentanyl group had sedation. The 
majority of the patients had mild sedation, patient awake but drowsy. 
This was statistically significant (p<0.001) as compared to nalbuphine 
group.
Pruritus
In this study, no patients in nalbuphine group and butorphanol group 
had pruritus whereas eight patients in fentanyl group had pruritus. 
Pruritus induced by epidural opioids is likely due to interaction with 
trigeminal nucleus in medulla.
DISCUSSION
Post-operative pain is acute pain, which starts with the surgical 
trauma and usually ends with tissue healing. It diminishes with time 
after surgery and responds to analgesics. The effective relief of pain 
Table 1: Demographic data
Age in years 34.4±11.9 33.8±10.53 34.67±10.80
Sex (female:male) 22:3 23:2 23:2




Table 2: Block characteristics
Time (minutes) Group A Group B Group C
Onset of analgesia 11.24±2.989 6.320±3.555 14.64±2.234
Range 7-18 5-9 10-19




Group A Group B Group C
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to the patients undergoing surgery is essential and is of paramount 
importance both on humanitarian grounds and also in reducing post-
operative morbidity, hence should be duly imparted by the treating 
anesthesiologist.
Severe pain can result in splinting, with resultant atelectasis and 
hypoxia. In addition, poor control of pain may result in increased 
catecholamine secretion in response to pain, which may in turn 
increase myocardial oxygen demand. A number of studies in the past 
have proved that improved post-operative analgesia may reduce the 
incidence of cardiac and pulmonary morbidity and mortality in patients 
undergoing major abdominal surgery.
Since the discovery of opioid receptors in the spinal cord, the action 
of narcotics through opioid receptors has become more clearly 
understood. One of the opioid receptors, kappa are mainly involved 
with the mediation of visceral pain. After this, achieving satisfactory 
post-operative analgesia with epidural and intrathecal administration 
of narcotics has been the subject of much research. The use of epidural 
opioids had become an increasingly popular technique for management 
of acute post-operative pain in recent times. However, there are 
disadvantages associated with narcotics as they are not always simple 
to use and may be associated with some unpleasant adverse effects 
such as nausea and vomiting (post-operative nausea and vomiting), 
pruritus, respiratory depression, and urinary retention.
Stimulation of spinal opiate receptors (kappa, ĸ) can also produce 
spinal analgesia but with fewer side effects. Therefore, a drug such 
as butorphanol, a mixed narcotic agonist/antagonist, acts as a mu (μ) 
agonist/antagonist and kappa agonist, also produces analgesia, 
associated with fewer side effects and also low abuse potential. 
Its high lipid solubility and high affinity for opioid receptors are 
additional factors that contribute to paucity of side effects with its 
use.
Fentanyl was chosen for the study for advantages such as no neurolytic 
preservatives, highly lipophilic, so better retained within the epidural 
Table 3: Complications
Complication Group A (%) Group B (%) Group C (%) p value
Nausea and 
vomiting
3 (12) 4 (16) 12 (48) 0.484
Urinary 
retention
4 (16) 1 (3.3) 0 (0.0) 0.6
Respiratory 
depression
0 (0.0) 0 (0.0) 0 (0.0) -
Sedation 8 (32) 7 (20) 2 (8) 0.001
Pruritus 0 8 0 <0.001
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space, short half-life, so less circulating blood levels resulting from 
absorption and finally because it is stable in salt solutions for more 
than 72 hrs.
Nalbuphine is an agonist - antagonist, equipotent to morphine also has 
a low abuse potential. It is known to produce profound analgesia and 
is known to be associated with side effects like sedation. It commonly 
finds its place in clinical practice as it has a ceiling effect on respiratory 
depression.
This study is a prospective randomized controlled clinical comparative 
study done to assess the efficacy and safety of epidural butorphanol, 
epidural fentanyl and epidural nalbuphine, each combined with 
0.125% bupivacaine for the management of post-operative pain. A total 
of 75 patients belonging to age groups 18-60 years were taken, out of 
which majority of patients belonged to 20-50 years of age. The patients 
undergoing elective lower abdominal surgeries in general surgery, 
gynecology, urology, and plastic surgery were selected.
The observations of the study were analyzed, and results revealed 
that onset of analgesia was faster in fentanyl group compared to other 
two groups. This could be correlated with the studies conducted by 
Mok and Tsai [9] who did a study to evaluate the analgesic efficacy 
and safety of epidural butorphanol (4 mg) in comparison to that 
of epidural morphine 5 mg in patients with post-operative pain. In 
their study, it was observed that the onset of pain relief with epidural 
butorphanol appeared at 15 minutes and peaked at 30 minutes. 
Kaur et al. [1] also studied epidural butorphanol and fentanyl 
as adjuvants in lower abdominal surgeries and demonstrated 
earlier onset with fentanyl when used with bupivacaine epidurally 
(mean 10.80 minutes) than with butorphanol used with bupivacaine 
epidurally (mean 11.08 minutes).
As regarding the duration of analgesia, the duration was thus 
significantly longer in butorphanol group. The above observation 
correlates with the works of Malik et al. [5] who used 2 mg butorphanol 
epidurally for post-operative analgesia after orthopedic surgeries and 
found duration to be 5.59±1.15 hrs after the first dose. Abboud et al. [10] 
noted the duration of analgesia to be 4.82±0.77 hrs, 5.53±0.86 hrs, 
8.05±0.97 hrs after use of the first dose of 1 mg, 2 mg, and 4 mg 
butorphanol used epidurally. Chatrath et al. [2] used 10 mg epidural 
nalbuphine along with 0.25% bupivacaine and found the duration to 
be 380±11.4 minutes after lower limb and hip surgeries. Kaur et al. [1] 
noted the duration of epidural fentanyl 100 µg with 20 ml bupivacaine 
was 3-9 hrs, mean duration being 5.96 hrs. Their study demonstrated 
that the duration was significantly greater in butorphanol group with a 
mean duration of 7.64 hrs.
Side effects of opioids include sedation, nausea, vomiting, pruritus, 
urinary retention, and respiratory depression. Pruritus was seen 
in 8 patients of fentanyl group. This is in accordance with findings 
of Abboud et al. [10] who found paucity of side effects with epidural 
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butorphanol given after cesarean section and attributed this to 
high lipid solubility of butorphanol thus limiting its cephalic spread 
to the brainstem. Chatrath et al. [2] studied the effects of epidural 
nalbuphine and tramadol for post-operative analgesia in orthopedic 
surgeries and concluded that patients were more comfortable after 
nalbuphine epidurally since they complained of lesser side effects. 
Sedation was observed in butorphanol group consistent with the study 
of Venkatraman et al. [4] who observed sedation in patients receiving 
epidural butorphanol.
CONCLUSION
Opioid analgesics with local anesthetics are extremely safe, effective 
and reliable method of post-operative pain relief. The addition of 
fentanyl produces faster onset of analgesia with adverse effects like 
sedation and pruritus than butorphanol and nalbuphine when given 
epidurally along with 0.125% bupivacaine. Butorphanol administered 
epidurally has advantage of longer duration of analgesia than fentanyl 
or epidural nalbuphine with side effects like nausea vomiting and 
sedation. Although none of the patients in this study developed 
respiratory depression, it is strongly recommended in concurrence 
with other authors that monitoring for clinical respiratory depression 
be made in all patients during the period of analgesia.
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